Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000514420 | SCV000611073 | likely benign | not provided | 2017-09-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000514420 | SCV001042400 | benign | not provided | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000989369 | SCV001139666 | likely benign | Osteochondritis dissecans | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000514420 | SCV002009055 | uncertain significance | not provided | 2021-04-05 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV003278859 | SCV003961733 | uncertain significance | Inborn genetic diseases | 2023-04-11 | criteria provided, single submitter | clinical testing | The c.230G>A (p.R77H) alteration is located in exon 3 (coding exon 2) of the ACAN gene. This alteration results from a G to A substitution at nucleotide position 230, causing the arginine (R) at amino acid position 77 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Laboratory of Diagnostic Genome Analysis, |
RCV000514420 | SCV002035579 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001796749 | SCV002037416 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004551656 | SCV004752409 | likely benign | ACAN-related disorder | 2019-04-02 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |